STOCKHOLDERS DEFICIT (Details Narrative)	1 Months Ended	12 Months Ended
	Dec. 18, 2019 $ / shares shares	Dec. 31, 2020 USD ($) integer $ / shares shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 shares	Dec. 04, 2017 shares
Common stock, par value | $ / shares		$ 0.00001	$ 0.00001
Common stock, authorized shares		800,000,000	800,000,000
Common stock, issued shares		75,056,123	75,056,123
Common stock, outstanding shares		75,056,123	75,056,123
Preferred stock, par value | $ / shares		$ 0.00001	$ 0.00001
Preferred stock, authorized shares		25,000,000	25,000,000
Stock-based compensation | $		$ 41,667	$ 57,999
Technology transfer agreement Description		A total of 960 shares of its common stock, payable in 8 quarterly installments of 120 shares.
Future compensation cost related to novested options not yet recognized | $		$ 41,667
Exercise price | $ / shares	$ 0.020
Options, Term of Expiration	10 years
Stock Options granted to purchase common stock	6,250,000
Description of Options expiration period		The outstanding options expire on various dates beginning in 2027 through 2029.
Common stock payable | $		$ 16,800	$ 16,800
Beginning Balance		7,762,821	7,768,421	1,518,421
Consultant [Member]
Stock Options granted to purchase common stock	2,500,000
2017 Stock Option Plan [Member]
Stock options outstanding shares		7,762,821	1,512,821
2017 Non-Qualified Stock Option Plan [Member] | Maximum [Member]
Option granted to purchase common shares					10,000,000
2006 Stock Option Plan [Member]
Beginning Balance		5,600
Preferred Shares Series C [Member]
Preferred stock, issued shares		4,355,000
Preferred stock, outstanding shares		4,355,000
Preferred stock series C, shares authorized | $		$ 4,500,000
Description of voting rights		(i) dividend rights equal to the Company’s common stock; (ii) no liquidation preference over the Company’s common stock; (iii) each share is convertible into 50 shares of the Company’s common stock; (iv) no redemption rights; (v) no call rights by the Company; and (vi) each shares votes on an “as converted” basis, such that each share currently has 50 votes on all matters brought before the Company’s common stockholders for a vote.
Series B Preferred Shares [Member]
Preferred Stock voting rights description		(i) dividend rights equal to the Company’s common stock; (ii) no liquidation preference over the Company’s common stock; (iii) each share is convertible into 50 shares of the Company’s common stock; (iv) no redemption rights; (v) no call rights by the Company; and (vi) each shares votes on an “as converted” basis, such that each share currently has 50 votes on all matters brought before the Company’s common stockholders for a vote. The holders of the Series B preferred stock cannot convert their shares of Series B preferred stock if such conversion would cause the holder to beneficially own more than 4.99% of our then-outstanding common stock.
Preferred stock, issued shares		2,480,482
Preferred stock, outstanding shares		2,480,482
Preferred stock series B, shares authorized | $		$ 2,700,000
Unrelated Party [Member]
Common stock, issued shares		960
Common stock payable | $		$ 16,800	$ 16,800
Shares per installment		120
Number of quarterly installments | integer		8
Craig Holland [Member] | Series A Preferred Shares [Member]
Preferred stock, authorized shares		1,000
Preferred Stock voting rights description		The aggregate 1,000 shares have votes equal to 51% of the then-outstanding voting rights of the Company (including all common stock and any other series of preferred stock) on any matter properly brought before the Company’s stockholders for a vote.
Mick Donahoo [Member]
Stock Options granted to purchase common stock	3,750,000